Cargando…
Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499859/ https://www.ncbi.nlm.nih.gov/pubmed/35931884 http://dx.doi.org/10.1038/s43018-022-00430-w |
_version_ | 1784795091229999104 |
---|---|
author | Spring, Laura M. Han, Hyo Liu, Minetta C. Hamilton, Erika Irie, Hanna Santa-Maria, Cesar A. Reeves, James Pan, Peng Shan, Ming Tang, Yongqiang Graham, Julie R. Hazard, Sebastien Ellisen, Leif W. Isakoff, Steven J. |
author_facet | Spring, Laura M. Han, Hyo Liu, Minetta C. Hamilton, Erika Irie, Hanna Santa-Maria, Cesar A. Reeves, James Pan, Peng Shan, Ming Tang, Yongqiang Graham, Julie R. Hazard, Sebastien Ellisen, Leif W. Isakoff, Steven J. |
author_sort | Spring, Laura M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9499859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-94998592022-09-24 Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer Spring, Laura M. Han, Hyo Liu, Minetta C. Hamilton, Erika Irie, Hanna Santa-Maria, Cesar A. Reeves, James Pan, Peng Shan, Ming Tang, Yongqiang Graham, Julie R. Hazard, Sebastien Ellisen, Leif W. Isakoff, Steven J. Nat Cancer Author Correction Nature Publishing Group US 2022-08-05 2022 /pmc/articles/PMC9499859/ /pubmed/35931884 http://dx.doi.org/10.1038/s43018-022-00430-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Spring, Laura M. Han, Hyo Liu, Minetta C. Hamilton, Erika Irie, Hanna Santa-Maria, Cesar A. Reeves, James Pan, Peng Shan, Ming Tang, Yongqiang Graham, Julie R. Hazard, Sebastien Ellisen, Leif W. Isakoff, Steven J. Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title_full | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title_fullStr | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title_full_unstemmed | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title_short | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer |
title_sort | author correction: neoadjuvant study of niraparib in patients with her2-negative, brca-mutated, resectable breast cancer |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499859/ https://www.ncbi.nlm.nih.gov/pubmed/35931884 http://dx.doi.org/10.1038/s43018-022-00430-w |
work_keys_str_mv | AT springlauram authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT hanhyo authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT liuminettac authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT hamiltonerika authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT iriehanna authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT santamariacesara authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT reevesjames authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT panpeng authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT shanming authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT tangyongqiang authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT grahamjulier authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT hazardsebastien authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT ellisenleifw authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer AT isakoffstevenj authorcorrectionneoadjuvantstudyofniraparibinpatientswithher2negativebrcamutatedresectablebreastcancer |